Meeting Coverage:

Association for Research in Vision & Ophthalmology

ARVO: 2018

Quarterly Dosing and AMD: A Cross-Trial Comparison

Show Description +

David Eichenbaum, MD, summarizes his ARVO presentation, which took a retrospective look at a number of pivotal trials in which patients received intravitreal anti-VEGF injections at quarterly intervals. He explains how patients do with this regimen, and talks about being able to detect and predict which patients can tolerate less frequent dosing.

Posted: 5/03/2018

Quarterly Dosing and AMD: A Cross-Trial Comparison

David Eichenbaum, MD, summarizes his ARVO presentation, which took a retrospective look at a number of pivotal trials in which patients received intravitreal anti-VEGF injections at quarterly intervals. He explains how patients do with this regimen, and talks about being able to detect and predict which patients can tolerate less frequent dosing.

Posted: 5/03/2018


Please log in to leave a comment.

More From ARVO: 2018 Coverage

Results From the STOMP-CSC Trial

Roger A. Goldberg, MD, MBA

A Future Role in Retina for Stem Cell and Gene Therapy?

Baruch D. Kuppermann, MD, PhD, Nathan C. Steinle, MD